Patents by Inventor Meghna Das Thakur

Meghna Das Thakur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT WITH ANTI-TIGIT ANTIBODIES AND PD-1 AXIS BINDING ANTAGONISTS
    Publication number: 20210395366
    Abstract: The present invention relates to the treatment of esophageal cancer, e.g., esophageal squamous cell carcinoma (ESCC) (e.g., advanced ESCC (e.g., unresectable, locally advanced, recurrent, and/or metastatic ESCC)). More specifically, the invention pertains to the treatment of patients having esophageal cancer by administering a combination of an anti-T-cell immunoreceptor with Ig and ITIM domains (TIGIT) antagonist antibody and a programmed death-1 (PD-1) axis binding antagonist.
    Type: Application
    Filed: January 26, 2021
    Publication date: December 23, 2021
    Inventors: Shi LI, Meghna Das Thakur HARRIS, Yifan WANG, Edward Namserk CHA, Feijiao GE
  • Method of treating a proliferative disease
    Patent number: 11007194
    Abstract: The present invention relates to a method of treating a patient with a serine/threonine kinase inhibitor wherein resistance to the treatment with a serine/threonine kinase inhibitor is suppressed by administering the serine/threonine kinase inhibitor on an intermittent dosing schedule.
    Type: Grant
    Filed: November 9, 2012
    Date of Patent: May 18, 2021
    Assignee: Array BioPharma Inc.
    Inventors: Darrin Stuart, Meghna Das Thakur
  • Method of Treating a Proliferative Disease
    Publication number: 20140275136
    Abstract: The present invention relates to a method of treating a patient with a serine/threonine kinase inhibitor wherein resistance to the treatment with a serine/threonine kinase inhibitor is suppressed by administering the serine/threonine kinase inhibitor on an intermittent dosing schedule.
    Type: Application
    Filed: November 9, 2012
    Publication date: September 18, 2014
    Applicant: Novartis AG
    Inventors: Darrin Stuart, Meghna Das Thakur